Related Experiment Video
Updated: Dec 29, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Intestinal ulcers as an initial finding in EBV-associated lymphoproliferative disorder: A case report
Sizhu Wang1, Yinghuan Dai2, Jie Zhang1
1Department of Gastroenterology.
Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder (LPD) can mimic Crohn disease in adults presenting with intestinal ulcers. Early and accurate diagnosis of EBV-LPD is crucial for appropriate management.
Area of Science:
- Gastroenterology
- Oncology
- Infectious Diseases
Background:
- Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder (LPD) is uncommon in adults and rarely presents with gastrointestinal manifestations.
- Intestinal ulcers due to EBV-LPD pose diagnostic challenges due to atypical clinical and pathological presentations.
Observation:
- A 26-year-old male presented with chronic diarrhea and abdominal pain, initially diagnosed as Crohn disease based on colonoscopy and pathology.
- Despite Infliximab treatment for presumed Crohn disease, the patient developed fever and hematochezia, with subsequent identification of EBV-associated T-cell proliferation disease.
Findings:
- Initial biopsies of intestinal ulcers were inconclusive for EBV-LPD, requiring re-examination and immunohistochemical analysis.
- Nasopharyngeal biopsies confirmed EBV-associated T-cell proliferation disease, highlighting the importance of thorough investigation in atypical cases.
Implications:
- EBV-associated T-cell LPD should be considered in the differential diagnosis of adult patients with unexplained intestinal ulcers, even when initial findings suggest common conditions like Crohn disease.
- Diagnostic tools such as repeated biopsies, gene rearrangement studies, EBV DNA quantification, and EBV-encoded RNA (EBER) in situ hybridization are valuable for diagnosing EBV-LPD.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Endocarditis II: Clinical Features of Infective Endocarditis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

